229 related articles for article (PubMed ID: 28101785)
1. Acinetobacter baumannii bacteraemia in patients with haematological malignancy: a multicentre retrospective study from the Infection Working Party of Jiangsu Society of Hematology.
Wang X; Zhang L; Sun A; Yang X; Sang W; Jiang Y; Cheng J; Wang J; Zhou M; Chen B; Ouyang J
Eur J Clin Microbiol Infect Dis; 2017 Jul; 36(7):1073-1081. PubMed ID: 28101785
[TBL] [Abstract][Full Text] [Related]
2. A case-control study to identify predictors of 14-day mortality following carbapenem-resistant Acinetobacter baumannii bacteraemia.
Nutman A; Glick R; Temkin E; Hoshen M; Edgar R; Braun T; Carmeli Y
Clin Microbiol Infect; 2014 Dec; 20(12):O1028-34. PubMed ID: 24930471
[TBL] [Abstract][Full Text] [Related]
3. Exposure to quinolones is associated with carbapenem resistance among colistin-susceptible Acinetobacter baumannii blood isolates.
Kopterides P; Koletsi PK; Michalopoulos A; Falagas ME
Int J Antimicrob Agents; 2007 Nov; 30(5):409-14. PubMed ID: 17851052
[TBL] [Abstract][Full Text] [Related]
4. Risk factors and clinical outcomes of patients with carbapenem-resistant Acinetobacter baumannii bacteremia.
Huang ST; Chiang MC; Kuo SC; Lee YT; Chiang TH; Yang SP; Ti-Yin ; Chen TL; Fung CP
J Microbiol Immunol Infect; 2012 Oct; 45(5):356-62. PubMed ID: 22575430
[TBL] [Abstract][Full Text] [Related]
5. Risk factors and outcome for colistin-resistant Acinetobacter nosocomialis bacteraemia in patients without previous colistin exposure.
Wang YC; Lee YT; Yang YS; Chen CT; Chiu CH; Yin T; Kuo SC; Chen TL; Lin JC; Wang FD; Fung CP; Chang FY
Clin Microbiol Infect; 2015 Aug; 21(8):758-64. PubMed ID: 25980356
[TBL] [Abstract][Full Text] [Related]
6. Risk factors of mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteremia.
Liu CP; Shih SC; Wang NY; Wu AY; Sun FJ; Chow SF; Chen TL; Yan TR
J Microbiol Immunol Infect; 2016 Dec; 49(6):934-940. PubMed ID: 25553994
[TBL] [Abstract][Full Text] [Related]
7. Multicentre study of risk factors for mortality in patients with Acinetobacter bacteraemia receiving colistin treatment.
Lee YT; Sun JR; Wang YC; Chiu CH; Kuo SC; Chen TL; ; Yang YS
Int J Antimicrob Agents; 2020 Jun; 55(6):105956. PubMed ID: 32278810
[TBL] [Abstract][Full Text] [Related]
8. Tigecycline in carbapenem-resistant Acinetobacter baumannii bacteraemia: susceptibility and clinical outcome.
Kim NH; Hwang JH; Song KH; Choe PG; Kim ES; Park SW; Kim HB; Kim NJ; Park WB; Oh MD
Scand J Infect Dis; 2013 Apr; 45(4):315-9. PubMed ID: 23113680
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the effect of appropriate antimicrobial therapy on mortality associated with Acinetobacter nosocomialis bacteraemia.
Kuo SC; Lee YT; Yang SP; Chiang MC; Lin YT; Tseng FC; Chen TL; Fung CP
Clin Microbiol Infect; 2013 Jul; 19(7):634-9. PubMed ID: 22776466
[TBL] [Abstract][Full Text] [Related]
10. Risk and Prognostic Factors for Multidrug-Resistant Acinetobacter Baumannii Complex Bacteremia: A Retrospective Study in a Tertiary Hospital of West China.
Liu Q; Li W; Du X; Li W; Zhong T; Tang Y; Feng Y; Tao C; Xie Y
PLoS One; 2015; 10(6):e0130701. PubMed ID: 26083415
[TBL] [Abstract][Full Text] [Related]
11. Impact of appropriate antimicrobial therapy on mortality associated with Acinetobacter baumannii bacteremia: relation to severity of infection.
Lee YT; Kuo SC; Yang SP; Lin YT; Tseng FC; Chen TL; Fung CP
Clin Infect Dis; 2012 Jul; 55(2):209-15. PubMed ID: 22495546
[TBL] [Abstract][Full Text] [Related]
12. Comparison of pneumonia- and non-pneumonia-related Acinetobacter baumannii bacteremia: Impact on empiric therapy and antibiotic resistance.
Teng SO; Yen MY; Ou TY; Chen FL; Yu FL; Lee WS
J Microbiol Immunol Infect; 2015 Oct; 48(5):525-30. PubMed ID: 25103719
[TBL] [Abstract][Full Text] [Related]
13. Carbapenem-resistant versus carbapenem-susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes.
Routsi C; Pratikaki M; Platsouka E; Sotiropoulou C; Nanas S; Markaki V; Vrettou C; Paniara O; Giamarellou H; Roussos C
Infection; 2010 Jun; 38(3):173-80. PubMed ID: 20224962
[TBL] [Abstract][Full Text] [Related]
14. Incidence and risk factors for carbapenem- and multidrug-resistant Acinetobacter baumannii bacteremia in hematopoietic stem cell transplantation recipients.
Kim SB; Min YH; Cheong JW; Kim JS; Kim SJ; Ku NS; Jeong SJ; Han SH; Choi JY; Song YG; Kim JM
Scand J Infect Dis; 2014 Feb; 46(2):81-8. PubMed ID: 24325335
[TBL] [Abstract][Full Text] [Related]
15. Mortality risk factors of Acinetobacter baumannii bacteraemia.
Choi JY; Park YS; Kim CO; Park YS; Yoon HJ; Shin SY; Kim YA; Song YG; Yong D; Lee K; Kim JM
Intern Med J; 2005 Oct; 35(10):599-603. PubMed ID: 16207259
[TBL] [Abstract][Full Text] [Related]
16. Acinetobacter baumannii and Acinetobacter genospecies 13TU and 3 bacteraemia: comparison of clinical features, prognostic factors and outcomes.
Lee YC; Huang YT; Tan CK; Kuo YW; Liao CH; Lee PI; Hsueh PR
J Antimicrob Chemother; 2011 Aug; 66(8):1839-46. PubMed ID: 21653602
[TBL] [Abstract][Full Text] [Related]
17. Comparison between bacteremia caused by carbapenem resistant Acinetobacter baumannii and Acinetobacter nosocomialis.
Yang YS; Lee YT; Tsai WC; Kuo SC; Sun JR; Yang CH; Chen TL; Lin JC; Fung CP; Chang FY
BMC Infect Dis; 2013 Jul; 13():311. PubMed ID: 23841753
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes of carbapenem-resistant Acinetobacter baumannii bloodstream infections: study of a 2-state monoclonal outbreak.
Munoz-Price LS; Zembower T; Penugonda S; Schreckenberger P; Lavin MA; Welbel S; Vais D; Baig M; Mohapatra S; Quinn JP; Weinstein RA
Infect Control Hosp Epidemiol; 2010 Oct; 31(10):1057-62. PubMed ID: 20715975
[TBL] [Abstract][Full Text] [Related]
19. Prospective multi-center evaluation on risk factors, clinical characteristics and outcomes due to carbapenem resistance in
Liu Y; Wang Q; Zhao C; Chen H; Li H; Wang H; Cares Network OBOT
J Med Microbiol; 2020 Jul; 69(7):949-959. PubMed ID: 32584215
[No Abstract] [Full Text] [Related]
20. Community-acquired bloodstream infections caused by Acinetobacter baumannii: A matched case-control study.
Chen CT; Wang YC; Kuo SC; Shih FH; Chen TL; How CK; Yang YS; Lee YT
J Microbiol Immunol Infect; 2018 Oct; 51(5):629-635. PubMed ID: 28701266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
